Sign in to view content

A Multicenter Post-Authorization Safety Study of Patients Treated With Voretigene Neparvovec-rzyl Gene Therapy in the United States: Interim Analysis at 3 Years

Aaron Nagiel, MD, PhD

Video
Published 2024

Related

This was not the medical retina you were looking for: Surgical Approaches in Medical Retina
Lejla Vajzovic, MD, FASRS
Updates from the Field
2021
Multicenter Randomized Sham-Controlled Double-Masked Phase 2b Clinical Trial of Multi-Characteristic Opsin in Patients With Advanced Retinitis Pigmentosa
Peter K. Kaiser, MD FASRS
Annual Meeting Talks
2022
Instrumentation & Devices Symposium 1
Annual Meeting Talks
2020

Category: Hereditary Retinal Disease & Genetics

See more